Ep 1. Addiction: A Psychedelic Cure?

Breakthrough is a television series that explores the latest advancements and cutting-edge technologies in the field of science and health. In season 2, episode 1 "Addiction: A Psychedelic Cure?", the show delves into the controversial use of psychedelic drugs as a possible cure for addiction.

The episode begins by introducing viewers to a man named Mark who has battled addiction for years. Mark has been addicted to heroin and crack cocaine, and he has tried numerous traditional treatments to overcome his addiction with no success. Mark has turned to an unconventional treatment, using the psychedelic drug ibogaine, to try and break his addiction cycle.

The show then moves on to explore the history of psychedelic drugs and their association with addiction. Psychedelics were first used in the 1950s and 60s as a potential treatment for addiction. However, the use of these drugs was quickly dismissed due to their association with the counterculture movement of the time. The use of psychedelic drugs for medical purposes was subsequently heavily restricted, and medical research ceased for several decades.

Today, some researchers are revisiting the potential benefits of psychedelics for treating addiction. One of the key players in this field is Dr. Gabor Maté, a Canadian physician who specializes in addiction treatment. Dr. Maté believes that the root of addiction is often unresolved trauma, and that psychedelic drugs can help patients open up and confront these traumas in a safe and supportive environment.

The show then moves on to explore the use of ibogaine as a treatment for addiction. Ibogaine is a psychedelic plant medicine that has been used for centuries in traditional African healing ceremonies. In recent years, it has gained popularity as a treatment for addiction, particularly for opioid addiction. Ibogaine works by disrupting the brain's dependence on addictive substances, and by inducing a powerful introspective experience.

The use of ibogaine is still highly controversial, as it is not yet approved by the FDA for medical use in the United States. However, there are several clinics around the world that offer ibogaine treatment, often at great expense. The episode follows Mark's journey to a clinic in Mexico, where he receives ibogaine treatment for his addiction.

Mark's experience with ibogaine is intense and transformative. He experiences vivid hallucinations and visions, and confrons some of the deeply buried traumas that have contributed to his addiction. Despite its potential benefits, ibogaine is not without risks. The drug can have serious physical side effects, and it can be dangerous for some individuals, particularly those with certain medical conditions.

Breakthrough's "Addiction: A Psychedelic Cure?" raises important questions about the use of psychedelics in treating addiction. While the potential benefits are clear, there are also many unanswered questions about the safety and efficacy of these treatments. The episode offers a thought-provoking exploration of this cutting-edge field of medical research, and challenges viewers to consider alternative approaches to addiction treatment.